Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.

Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.

Item
http://www.wikidata.org/entity/Q54085824
Inducible resistance to Fas-mediated apoptosis in B cells.Drug-resistance in human melanoma.Cellular FLICE-inhibitory protein: an attractive therapeutic target?The small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer.Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy.Interferon-alpha and interferon-gamma modulate Fas-mediated apoptosis in mitomycin-C-resistant human Tenon's fibroblasts.Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma.IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.Direct growth suppressive activity of interferon-alpha and -gamma on human gastric cancer cells.
P2860

Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.

Item
http://www.wikidata.org/entity/Q54085824
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@en
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@nl
type
label
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@en
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@nl
prefLabel
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@en
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Heterogenous susceptibility to ...... odulation by interferon-gamma.
@en
P2093
P2860
P304
P31
P356
10.1002/(SICI)1097-0215(19990827)82:5<727::AID-IJC17>3.0.CO;2-E
P433
P478
P577
P698